Free Trial

Comerica (CMA) Stock Forecast & Price Target

Comerica logo
$70.09 -0.14 (-0.20%)
(As of 11/14/2024 ET)

Comerica - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
3
Hold
11
Buy
8

Based on 22 Wall Street analysts who have issued ratings for Comerica in the last 12 months, the stock has a consensus rating of "Hold." Out of the 22 analysts, 3 have given a sell rating, 11 have given a hold rating, and 8 have given a buy rating for CMA.

Consensus Price Target

$62.81
-10.39% Downside
According to the 22 analysts' twelve-month price targets for Comerica, the average price target is $62.81. The highest price target for CMA is $75.00, while the lowest price target for CMA is $51.00. The average price target represents a forecasted downside of -10.39% from the current price of $70.09.
Get the Latest News and Ratings for CMA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Comerica and its competitors.

Sign Up

CMA Analyst Ratings Over Time

TypeCurrent Forecast
11/16/23 to 11/15/24
1 Month Ago
10/17/23 to 10/16/24
3 Months Ago
8/18/23 to 8/17/24
1 Year Ago
11/16/22 to 11/16/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
6 Buy rating(s)
10 Buy rating(s)
Hold
11 Hold rating(s)
11 Hold rating(s)
14 Hold rating(s)
8 Hold rating(s)
Sell
3 Sell rating(s)
3 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$62.81$59.62$55.45$54.19
Forecasted Upside-10.39% Downside-4.36% Downside-1.36% Downside22.22% Upside
Consensus Rating
Hold
Hold
Hold
Hold

CMA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CMA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Comerica Stock vs. The Competition

TypeComericaFinance CompaniesS&P 500
Consensus Rating Score
2.23
2.49
2.50
Consensus RatingHoldHoldModerate Buy
Predicted Upside-10.39% Downside10.06% Upside8.87% Upside
News Sentiment Rating
Neutral News

See Recent CMA News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/30/2024Evercore ISI
2 of 5 stars
 Boost TargetIn-Line ➝ In-Line$64.00 ➝ $69.00+7.04%
10/22/2024The Goldman Sachs Group
2 of 5 stars
 Boost TargetBuy ➝ Buy$63.00 ➝ $71.00+14.68%
10/21/2024Morgan Stanley
3 of 5 stars
 Boost TargetEqual Weight ➝ Equal Weight$63.00 ➝ $67.00+7.11%
10/21/2024DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$64.00 ➝ $68.00+8.07%
10/21/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$65.00 ➝ $70.00+10.27%
10/21/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$64.00 ➝ $70.00+10.27%
10/21/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$43.00 ➝ $51.00-19.66%
10/21/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$66.00 ➝ $70.00+10.27%
10/21/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$56.00 ➝ $66.00+1.65%
10/7/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$55.00 ➝ $52.00-11.65%
9/24/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Chiaverini
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$52.00 ➝ $75.00+24.61%
9/5/2024Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Mcgratty
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$50.00 ➝ $69.00+25.84%
7/22/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$58.00 ➝ $56.00+12.13%
7/22/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$51.00 ➝ $52.00+3.75%
7/2/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Rose
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$60.00+18.11%
6/20/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$72.00 ➝ $68.00+44.25%
5/6/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$60.00 ➝ $56.00+5.52%
4/19/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$59.00 ➝ $55.00+6.80%
4/10/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$59.00+8.30%
4/8/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$65.00 ➝ $60.00+10.76%
1/29/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
1/18/2024Bank Of America (Bofa)
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$52.00 ➝ $55.00+5.95%
9/26/2023Odeon Capital Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$46.00+11.03%
6/29/202358.com
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
5/3/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Peer Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:01 AM ET.


CMA Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Comerica is $62.81, with a high forecast of $75.00 and a low forecast of $51.00.

22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Comerica in the last twelve months. There are currently 3 sell ratings, 11 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CMA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CMA, but not buy additional shares or sell existing shares.

According to analysts, Comerica's stock has a predicted downside of -10.39% based on their 12-month stock forecasts.

Over the previous 90 days, Comerica's stock had 2 upgrades and 1 downgrade by analysts.

Analysts like Comerica less than other "finance" companies. The consensus rating score for Comerica is 2.23 while the average consensus rating score for "finance" companies is 2.49. Learn more on how CMA compares to other companies.


This page (NYSE:CMA) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners